The focus of our 2019 GM conference, The Ageing Patient: Midlife and Beyond, is maintaining wellness in midlife and beyond.
This year, we are dividing the programme into two sessions. During the morning session we will review primary and secondary prevention strategies for patients aged over 50 years. Then in our afternoon session we will focus on promoting and maintaining independence in frail older populations.
If you are a healthcare professional with an interest in the older patient, this programme is for you.
Peter Passmore, Professor of Ageing and Geriatric Medicine at Queen’s University, will be chairing the day’s programme. Speaker sessions will bring you updates on national guidelines, new treatments, early identification of age-related disease, and best practice in managing frailty, sarcopenia and falls.
This programme has been awarded six CPD points, the maximum applicable for a one-day medical conference.
The Ageing Patient: Midlife and Beyond brings practical advice to GPs, geriatricians, old age psychiatrists, specialists with an interest in 50+ medicine, specialist nurses, commissioners, Clinical Commissioning Group members, and associated healthcare professionals.
Morning session: Prevention strategies in midlife patients
09.30–10.00: Registration and coffee
10.00–10.30: Chair’s introduction
10.30–11.15: Bone health and the prevention of fractures, Dr Michael Stone, Consultant Physician and Director of Bone Research at the Bone Research Unit, Cardiff
11.15–11.45: Cancer prevention, screening and diagnostic red flags, Professor Margot Gosney, Honorary Consultant in Elderly Care Medicine at the Royal Berkshire NHS Foundation Trust
11.45–12.00 Coffee break
12.00–12.30: Improving the physical health of people with serious mental illness, Kate Dale, Project Lead, Bradford District Care Trust
12.30-13.00: Diabetes-related diseases and how to prevent them? Dr Martin Hadley-Brown, GP partner in Norfolk
Afternoon session: Managing frailty in a comorbid patient
14.00–14.45: Falls prevention, ProfessorCameron Swift, Emeritus Professor of Health Care of the Elderly, King’s College School of Medicine, London and Past President of the British Geriatrics Society
14.45–15.30: What’s new in sarcopenia? Dr Sanjay Suman, Consultant Physician, Medway NHS Foundation Trust
15.30–15.45: Coffee break
15.45–16.30: Polypharmacy and deprescribing: where to start? Dr Jennifer Stevenson, Clinical Academic Pharmacist, King’s College, London and Guy’s and St. Thomas’ Hospital
16.30–17.00: Frailty and cognitive impairment, Professor Peter Passmore, Consultant Physician, Belfast City Hospital
17.00–17.30: Chair’s summary
*Please note the order of sessions is subject to change.
Session: Improving The Physical Health for People with serious mental illness
Kate Dale has 40 years’ experience working in mental health both with in-patients and as a community psychiatric nurse (CPN). This has included working as Assertive Outreach Lead covering 500 square miles of the Yorkshire Dales.
Over the past 16 years Kate Dale has taken a passionate interest in the physical health of people who have a SMI. This has included involvement in a national pilot and more recently in local implementation of a process to make a difference in the way we address and intervene with the physical health of this population.
In Bradford and Airedale they have developed and implemented a template both in Primary and Secondary Care which guides clinicians through a standardised systematic physical health check.
This work is now gathering national interest and is in line with the “Lester tool”, which is a national recognised tool to support improvement when carrying out physical health monitoring for patients with SMI.
Professor Margot Gosney
Session: Cancer prevention, screening and diagnostic red flags
Honorary Consultant in Elderly Care Medicine at the Royal Berkshire NHS Foundation Trust
Margot Gosney began her studies in medicine at the University of Liverpool. She decided on a career in Geriatric Medicine during her undergraduate days and spent her final year elective researching adverse drug reactions and potential interactions in elderly hospitalised people. This resulted in her first publication in The Lancet.
In 1992, she was appointed Senior Lecturer at the University of Liverpool, in 2003 appointed Director of Clinical Health Sciences, University of Reading and Honorary Consultant in Elderly Care Medicine at the Royal Berkshire NHS Foundation Trust.
She has published extensively in oncology, nutrition and influenza.
She is one of a few Geriatricians in the United Kingdom who is also trained in Medical Oncology. She has set up and run a Comprehensive Care for Older People with Cancer service in Berkshire and has advised the Department of Health and Macmillan Cancer Care on the management of older people with cancer. She has written books, chapters and peer reviewed papers as well as guidelines on the management of cancer in older people.
Dr Martin Hadley-Brown
Session: Diabetes related diseases and how to prevent them
Martin Hadley-Brown was one of the founder members of the PCDS and then its Chair from 2005 to 2012. He is a six-session GP Partner in Norfolk and also is contracted by the University of Cambridge Clinical School, where he is heavily involved in teaching, principally on the Graduate Entry Course. He works with GP Trainees in the practice and undertakes multi-professional training work in the Eastern region.
He was a member of the NICE type 2 diabetes guidelines group for the 2008–10 publications, and he continues as a Clinical Adviser to the Royal College of General Practitioners. He also represents the PCDS within the “General Assembly” of Primary Care Diabetes Europe, where the PCDS is the largest national group.
Chair: Professor Peter Passmore
Session: Frailty and cognitive impairment
Professor of Ageing and Geriatric Medicine, Queen’s University Belfast
Professor Passmore is a graduate of Queen’s University, Belfast. He was appointed as Senior Lecturer at Queen’s University in January 1993; Reader in October 2005; and his current appointment dates from October 2007. He has a long-standing interest in the management of cardiovascular disease in older people. As well as managing older patients with general diseases, he has also managed the Stroke Unit. He is the consultant in administrative charge of the Memory Clinic at Belfast City Hospital. Research interests include cardiovascular disease in older people, stroke and dementia. Professor Passmore has published widely on subjects ranging from cardiovascular pharmacology to drugs in older people.
Dr Jennifer Stevenson
Session: Polypharmacy and deprescribing: where to start?
Dr Jennifer Stevenson is a Clinical Academic Pharmacist specialising in the optimisation of medicines in older adults. Her research, more specifically, has focused on advancing our understanding of medication related harm in older patients living with frailty and how to identify those at greatest risk of harm. Her clinical speciality, as a pharmacist at Guy’s and St. Thomas’ Hospital, is older adults. She also supports teaching across undergraduate and postgraduate pharmacy courses at King’s College London.
Dr Mike Stone
Session: Bone health and the prevention of fractures
Consultant Physician and Director of Bone Research at the Bone Research Unit, Cardiff
Dr Michael Stone qualified from Oxford University in 1981 before completing his clinical training in London. He trained in metabolic bone disease under the auspices of Professor David Hosking in Nottingham culminating in the award of his DM thesis in the Treatment of Paget’s disease of bone.
Since his move to Cardiff he has developed one of the busiest metabolic bone disease units in the UK. There are four bone clinics each week and open access bone densitometry serviced by two DXA scanners. He is also Director of the Bone Research
Unit in the Geriatric Medicine Department of Cardiff University with his main research interests lying in novel methods of bone strength assessment, the bisphosphonate acute
phase response, bone loss in patients with cystic fibrosis or COPD, as well as the use of high dose vitamin D in the frail elderly. He is Chairman of the All Wales Osteoporosis Advisory Group and a specialist adviser UK for the National Osteoporosis Society.
Dr Sanjay Suman
Session: What’s new in sarcopenia?
Consultant Physician, Medway NHS Foundation Trust
Dr Sanjay Suman was appointed as Consultant Physician in Elderly Care at Medway NHS Foundation Trust in 2007 after completing higher specialist training in Geriatrics and General
Medicine: Cambridge Deanery, East Anglia. He is currently the clinical lead for the Elderly Care Department.
He has been active in developing services in the community (falls and syncope clinic, care home support team) as well as the hospital (Acute Frailty Pathway). His special interests include falls and syncope in the elderly, polypharmacy reduction and education. He has also developed a number of local clinical management guidelines including falls, delirium and constipation management for older patients.
He has been a guest speaker at a number of regional and national educational events.
Professor Cameron Swift
Session: Falls prevention in the frail patient
Emeritus Professor and Consultant Physician, King’s College London and Committee Member Falls Prevention Quality Standard, NICE
Cameron Swift is a physician, geriatrician and clinical pharmacologist, Emeritus Professor of Health Care of the Elderly at King’s College School of Medicine, London, and former President of the British Geriatrics Society (BGS). He served on the NICE Clinical Guideline Development Group (GDG) for Falls Prevention (CG24/161; 2004/2013), and has been Chairman of the NICE GDG, & subsequent Quality Standard Topic Expert Group for Hip Fracture (CG124, QS86) (2011, 2012). He remains involved as an expert member in current updates of NICE guidance (2014) and Quality Standards (2016-17) on both topics.
Previously he kick-started the BGS Special Interest Group on Falls & Bone Health, and as Physician to the DOH External Reference Group for the former England National Service Framework for Older People, he chaired the Working Party for Standard 6 (Falls & Fractures). As a clinical pharmacologist he served for 6 years on the UK Committee on Safety of Medicines and then for 5 more on the Medicines Commission (now both subsumed into the Commission on Human Medicines). The related commitment to a transparent evidence hierarchy as the basis for progress and investment remains a preoccupation.